The deal adds RTC’s range of Certified Reference Substances (CRS) and capabilities in design, development and packaging of analytical standards and matrix standards, to Sigma’s offering as VP of analytical research Russel Gant explained.
"Their experienced team, capabilities and customer contacts combine nicely with our breadth of product, high-quality portfolio, extensive scientific knowledge and global footprint. The RTC acquisition will allow Sigma-Aldrich to provide customers with an even broader range of specialized, analytical standards and services.”
Sigma already produce it’s a range of reagents, standards and separation consumables, including Supelco and Fluka brands that are already widely used in the drug manufacturing sector.
Pharma standards expansion
The RTC acquisition, financial terms of which were not provided, also follows hot on the heels of the US group’s acquisition of fellow pharmaceutical standards supplier Cerilliant.
That deal, which was completed in December last year, added Cerilliant’s range of high quality reference standards and materials for the pharmaceutical manufacturing, forensic science and clinical toxicology markets to Sigma’s portfolio.
At the time Gant said: “Cerilliant’s strong product suite and solid relationships with customers and analytical equipment suppliers will bring important new business opportunities to our company’s analytical arena.”